ID 417879969 · FY 2018–2023 · 6 years
New Pharma / NEW PHARMA (ნიუ ფარმა, ID 417879969, newpharma.ge) — a Tbilisi-based pharmaceutical import and wholesale representative (18 Evdoshvili St.). Revenue peaked around GEL 13.7m in 2021 then collapsed (≈GEL 0.9k by 2023) — effectively defunct. Distinct from the similarly-named 'ნიუ ფარმა' with ID 417887139.
curated 2026-06-25
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|---|---|---|
| Total Revenue | 5,012 | 6,853 | 6,002 | 13,680 | 4,110 | 1 | nmf |
| Total COGS | -2,652 | -2,743 | -2,486 | -6,903 | -1,857 | 0 | -8.5% |
| Gross Profit | 2,360 | 4,110 | 3,517 | 6,777 | 2,253 | 1 | nmf |
| Gross Margin | 47.1% | 60.0% | 58.6% | 49.5% | 54.8% | 100.0% | |
| Total Operating Expenses | -3,848 | -2,460 | -3,990 | -4,042 | -2,729 | -263 | -41.5% |
| EBITDA | -1,488 | 1,650 | -474 | 2,735 | -476 | -262 | -29.3% |
| EBITDA Margin | -29.7% | 24.1% | -7.9% | 20.0% | -11.6% | -29687.2% | |
| Total D&A | -12 | -11 | -13 | -14 | -9 | 0 | -7.3% |
| EBIT / Operating Income | -1,500 | 1,639 | -487 | 2,721 | -485 | -262 | -29.5% |
| Total Interest Expense | -59 | -52 | -4 | -9 | 0 | -0 | nmf |
| Total Other Income | 0 | 0 | 0 | 0 | 0 | 5 | |
| Profit Before Tax | -1,560 | 1,587 | -491 | 2,712 | -485 | -257 | -30.2% |
| Total Income Tax | 0 | -63 | -22 | -107 | -250 | 0 | +58.7% |
| Net Profit / (Loss) | -1,488 | 1,587 | -496 | 2,627 | -726 | -258 | -29.5% |
| Net Margin | -29.7% | 23.2% | -8.3% | 19.2% | -17.7% | -29249.2% |
Ownership & directors from companyinfo.ge (public corporate registry).